Rare diseases
Investigational molecules
Locations
Albert-Einstein-Allee 29, Eselsberg, 89081 Ulm, Germany
Clinical research at Universitaetsklinikum Ulm AöR includes Waldenström’s macroglobulinemia, marginal zone lymphoma, and acute myeloid leukemia, with attention to both newly diagnosed and relapsed disease.
The portfolio reflects interest in B-cell lymphoproliferative disorders and myeloid neoplasms, including genetically defined AML subgroups.
Universitaetsklinikum Ulm AöR runs clinical trials in conditions such as Waldenstrom's macroglobulinaemia, Nodal marginal zone B-cell lymphoma, Splenic marginal zone lymphoma, Extranodal marginal zone B-cell lymphoma (MALT type), among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyGermanyGermany
AustriaGermanyGermanyGermanyGermanyAustriaAustriaGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
